Bilateral Salmonella Epididymo-Orchitis as the Presenting Manifestation of Undiagnosed HIV Infection: A Case Report

Authors

  • Anastasios Dimou Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece Author
  • Maria Beltsiou Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece Author
  • Ilias Kanakakis Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece Author
  • Dimitrios Tzortzakakis Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece Author
  • Stavros Tzoulakis1 Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece Author

DOI:

https://doi.org/10.47363/nxgc4p15

Keywords:

Salmonella Epididymo-orchitis, Bilateral Orchitis, HIV, Immunocompromised, Non-Typhoidal Salmonella, Ciprofloxacin, Case Report

Abstract

Background: Non-typhoidal Salmonella (NTS) is a predominant cause of foodborne gastroenteritis worldwide but rarely produces invasive urogenital
infections. NTS-induced epididymo-orchitis has been reported in fewer than 20 cases in the literature, all unilateral, predominantly in immunocompromised individuals. Bilateral NTS epididymo-orchitis has not previously been reported, and its association with newly diagnosed HIV infection makes this case unique.

Case Summary: A 42-year-old male presented with a 3-day history of bilateral scrotal pain, erythema, and fever. Laboratory investigations showed leukocytosis (WBC 12,100/mm³), markedly elevated CRP (19.4 mg/dL), and heavy pyuria (463 WBC/HPF). Scrotal Doppler ultrasound confirmed bilateral epididymoorchitis without abscess. Urine culture yielded Salmonella enterica, sensitive to fluoroquinolones. HIV-1/2 serology was reactive with a positive viral load (737.21 copies/mL). Oral ciprofloxacin 500 mg twice daily was administered for 4 weeks, resulting in complete clinical and biochemical resolution. No recurrence was observed at 6 months. The patient was referred for antiretroviral therapy.

Author Biographies

  • Anastasios Dimou, Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece

    Anastasios Dimou, Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece.

  • Maria Beltsiou, Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece

    Anastasios Dimou, Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece.

  • Ilias Kanakakis, Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece

    Anastasios Dimou, Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece.

  • Dimitrios Tzortzakakis, Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece

    Anastasios Dimou, Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece.

  • Stavros Tzoulakis1, Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece

    Anastasios Dimou, Urology Department, Venizeleio General Hospital of Heraklion, Heraklion, Crete, Greece.

Downloads

Published

2026-10-05